These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15012772)

  • 1. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
    Chitturi S; Farrell GC; George J
    J Gastroenterol Hepatol; 2004 Apr; 19(4):368-74. PubMed ID: 15012772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.
    Chitturi S; Farrell GC; Hashimoto E; Saibara T; Lau GK; Sollano JD;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):778-87. PubMed ID: 17565630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
    Amarapurkar DN; Hashimoto E; Lesmana LA; Sollano JD; Chen PJ; Goh KL;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):788-93. PubMed ID: 17565631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.
    Farrell GC; Chitturi S; Lau GK; Sollano JD;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629
    [No Abstract]   [Full Text] [Related]  

  • 6. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease guidelines: an Asian perspective.
    Ishii H; Kajihara M
    J Gastroenterol Hepatol; 2007 Jun; 22(6):769-70. PubMed ID: 17565626
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current trends of NASH/NAFLD in Asia-Pacific region].
    Ishii H
    Nihon Rinsho; 2006 Jun; 64(6):1017-9. PubMed ID: 16768103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.
    Wong VW; Chan WK; Chitturi S; Chawla Y; Dan YY; Duseja A; Fan J; Goh KL; Hamaguchi M; Hashimoto E; Kim SU; Lesmana LA; Lin YC; Liu CJ; Ni YH; Sollano J; Wong SK; Wong GL; Chan HL; Farrell G
    J Gastroenterol Hepatol; 2018 Jan; 33(1):70-85. PubMed ID: 28670712
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.
    Sarin SK; Kumar M; Eslam M; George J; Al Mahtab M; Akbar SMF; Jia J; Tian Q; Aggarwal R; Muljono DH; Omata M; Ooka Y; Han KH; Lee HW; Jafri W; Butt AS; Chong CH; Lim SG; Pwu RF; Chen DS
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):167-228. PubMed ID: 31852635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?
    Farrell GC
    J Gastroenterol Hepatol; 2003 Feb; 18(2):124-38. PubMed ID: 12542595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pakistan? Non alcoholic fatty liver disease.
    Parkash O; Hamid S
    J Pak Med Assoc; 2013 Jan; 63(1):95-9. PubMed ID: 23865141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liver and the waistline: Fifty years of growth.
    Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S105-18. PubMed ID: 19799688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New trends on obesity and NAFLD in Asia.
    Fan JG; Kim SU; Wong VW
    J Hepatol; 2017 Oct; 67(4):862-873. PubMed ID: 28642059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.
    Vongsuvanh R; van der Poorten D; George J
    Hepatol Int; 2013 Dec; 7 Suppl 2():823-32. PubMed ID: 26202297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease: an emerging liver disease in Taiwan.
    Hsu CS; Kao JH
    J Formos Med Assoc; 2012 Oct; 111(10):527-35. PubMed ID: 23089687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
    Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015).
    Goh KL
    J Clin Gastroenterol; 2017 Jul; 51(6):479-485. PubMed ID: 28591070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.